Floatz logo

Therapeutic Asset Ratings

5,108 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Dexasone
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Novartis PharmaceuticalsP3BB (64)
Dexasone
Chronic Myelomonocytic Leukemia
Indiana UniversityP3BB (64)
Dexasone
Hodgkins Lymphoma
University of CologneP3BB (64)
Dexasone
Myelodysplastic Syndrome
Andrew E. Place, MDP3BB (64)
Dexasone
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkP3BB (64)
Diclofenac
Sciatica
Pakistan Institute of Medical SciencesP3BB (64)
Docetaxel
Castration-Resistant Prostate Carcinoma
Charles Drew University of Medicine and ScienceP3BB (64)
Docetaxel
Carcinoma Of Esophagus
NuCana plcP3BB (64)
Docetaxel
Fallopian Tube Cancer
Genelux CorporationP3BB (64)
Docetaxel
Gastric Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P3BB (64)
Docetaxel
Metastatic Malignant Neoplasm
InSilico Medicine Hong Kong LimitedP3BB (64)
Docetaxel
Metastatic Prostate Carcinoma
Georgetown UniversityP3BB (64)
Docetaxel
Ovarian Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P3BB (64)
Donanemab
Central Nervous System Disorder
Eli Lilly and CompanyP3BB (64)
Efanesoctocog Alfa
Severe Hemophilia A
Swedish Orphan BiovitrumP3BB (64)
Efruxifermin
Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, IncP3BB (64)
Eftrenonacog Alfa
Hemophilia B
Hospices Civils de LyonP3BB (64)
Eliglustat
Gaucher Disease Type III
SanofiP3BB (64)
Elotuzumab
Plasma Cell Myeloma
Hoffmann-La RocheP3BB (64)
Enicepatide
Obesity Disorder
Hoffmann-La RocheP3BB (64)
Enicepatide
Type 2 Diabetes Mellitus
Hoffmann-La RocheP3BB (64)
Epirubicin
Fallopian Tube Cancer
OncoC4, Inc.P3BB (64)
Epirubicin
Gastric Cancer
Rondo TherapeuticsP3BB (64)
Epirubicin
Lung Cancer
City of Hope Medical CenterP3BB (64)
Eribulin
Breast Carcinoma
Sun Yat-sen UniversityP3BB (64)
Showing 1701 to 1725 of 5,108 assets
PreviousPage 69 of 205Next